Attention Deficit Hyperactivity Disorder Market - Global Outlook and Forecast 2023-2028

Report ID: 1091556 | Published Date: Jan 2025 | No. of Page: 67 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Attention Deficit Hyperactivity Disorder Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Attention Deficit Hyperactivity Disorder Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Attention Deficit Hyperactivity Disorder Overall Market Size
    2.1 Global Attention Deficit Hyperactivity Disorder Market Size: 2021 VS 2028
    2.2 Global Attention Deficit Hyperactivity Disorder Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Attention Deficit Hyperactivity Disorder Players in Global Market
    3.2 Top Global Attention Deficit Hyperactivity Disorder Companies Ranked by Revenue
    3.3 Global Attention Deficit Hyperactivity Disorder Revenue by Companies
    3.4 Top 3 and Top 5 Attention Deficit Hyperactivity Disorder Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Attention Deficit Hyperactivity Disorder Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Attention Deficit Hyperactivity Disorder Players in Global Market
        3.6.1 List of Global Tier 1 Attention Deficit Hyperactivity Disorder Companies
        3.6.2 List of Global Tier 2 and Tier 3 Attention Deficit Hyperactivity Disorder Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Attention Deficit Hyperactivity Disorder Market Size Markets, 2021 & 2028
        4.1.2 Stimulants Drugs
        4.1.3 Non-stimulants Drugs
    4.2 By Type - Global Attention Deficit Hyperactivity Disorder Revenue & Forecasts
        4.2.1 By Type - Global Attention Deficit Hyperactivity Disorder Revenue, 2017-2022
        4.2.2 By Type - Global Attention Deficit Hyperactivity Disorder Revenue, 2023-2028
        4.2.3 By Type - Global Attention Deficit Hyperactivity Disorder Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Attention Deficit Hyperactivity Disorder Market Size, 2021 & 2028
        5.1.2 Pediatric
        5.1.3 Adolescent
        5.1.4 Adults
    5.2 By Application - Global Attention Deficit Hyperactivity Disorder Revenue & Forecasts
        5.2.1 By Application - Global Attention Deficit Hyperactivity Disorder Revenue, 2017-2022
        5.2.2 By Application - Global Attention Deficit Hyperactivity Disorder Revenue, 2023-2028
        5.2.3 By Application - Global Attention Deficit Hyperactivity Disorder Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Attention Deficit Hyperactivity Disorder Market Size, 2021 & 2028
    6.2 By Region - Global Attention Deficit Hyperactivity Disorder Revenue & Forecasts
        6.2.1 By Region - Global Attention Deficit Hyperactivity Disorder Revenue, 2017-2022
        6.2.2 By Region - Global Attention Deficit Hyperactivity Disorder Revenue, 2023-2028
        6.2.3 By Region - Global Attention Deficit Hyperactivity Disorder Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Attention Deficit Hyperactivity Disorder Revenue, 2017-2028
        6.3.2 US Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
        6.3.3 Canada Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
        6.3.4 Mexico Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Attention Deficit Hyperactivity Disorder Revenue, 2017-2028
        6.4.2 Germany Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
        6.4.3 France Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
        6.4.4 U.K. Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
        6.4.5 Italy Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
        6.4.6 Russia Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
        6.4.7 Nordic Countries Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
        6.4.8 Benelux Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Attention Deficit Hyperactivity Disorder Revenue, 2017-2028
        6.5.2 China Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
        6.5.3 Japan Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
        6.5.4 South Korea Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
        6.5.5 Southeast Asia Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
        6.5.6 India Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Attention Deficit Hyperactivity Disorder Revenue, 2017-2028
        6.6.2 Brazil Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
        6.6.3 Argentina Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Attention Deficit Hyperactivity Disorder Revenue, 2017-2028
        6.7.2 Turkey Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
        6.7.3 Israel Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
        6.7.4 Saudi Arabia Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
        6.7.5 UAE Attention Deficit Hyperactivity Disorder Market Size, 2017-2028
7 Players Profiles
    7.1 Eli Lilly
        7.1.1 Eli Lilly Corporate Summary
        7.1.2 Eli Lilly Business Overview
        7.1.3 Eli Lilly Attention Deficit Hyperactivity Disorder Major Product Offerings
        7.1.4 Eli Lilly Attention Deficit Hyperactivity Disorder Revenue in Global Market (2017-2022)
        7.1.5 Eli Lilly Key News
    7.2 Novartis
        7.2.1 Novartis Corporate Summary
        7.2.2 Novartis Business Overview
        7.2.3 Novartis Attention Deficit Hyperactivity Disorder Major Product Offerings
        7.2.4 Novartis Attention Deficit Hyperactivity Disorder Revenue in Global Market (2017-2022)
        7.2.5 Novartis Key News
    7.3 Takeda
        7.3.1 Takeda Corporate Summary
        7.3.2 Takeda Business Overview
        7.3.3 Takeda Attention Deficit Hyperactivity Disorder Major Product Offerings
        7.3.4 Takeda Attention Deficit Hyperactivity Disorder Revenue in Global Market (2017-2022)
        7.3.5 Takeda Key News
    7.4 Pfizer
        7.4.1 Pfizer Corporate Summary
        7.4.2 Pfizer Business Overview
        7.4.3 Pfizer Attention Deficit Hyperactivity Disorder Major Product Offerings
        7.4.4 Pfizer Attention Deficit Hyperactivity Disorder Revenue in Global Market (2017-2022)
        7.4.5 Pfizer Key News
    7.5 GlaxoSmithKline
        7.5.1 GlaxoSmithKline Corporate Summary
        7.5.2 GlaxoSmithKline Business Overview
        7.5.3 GlaxoSmithKline Attention Deficit Hyperactivity Disorder Major Product Offerings
        7.5.4 GlaxoSmithKline Attention Deficit Hyperactivity Disorder Revenue in Global Market (2017-2022)
        7.5.5 GlaxoSmithKline Key News
    7.6 Mallinckrodt
        7.6.1 Mallinckrodt Corporate Summary
        7.6.2 Mallinckrodt Business Overview
        7.6.3 Mallinckrodt Attention Deficit Hyperactivity Disorder Major Product Offerings
        7.6.4 Mallinckrodt Attention Deficit Hyperactivity Disorder Revenue in Global Market (2017-2022)
        7.6.5 Mallinckrodt Key News
    7.7 Hisamitsu
        7.7.1 Hisamitsu Corporate Summary
        7.7.2 Hisamitsu Business Overview
        7.7.3 Hisamitsu Attention Deficit Hyperactivity Disorder Major Product Offerings
        7.7.4 Hisamitsu Attention Deficit Hyperactivity Disorder Revenue in Global Market (2017-2022)
        7.7.5 Hisamitsu Key News
    7.8 Johnson & Johnson
        7.8.1 Johnson & Johnson Corporate Summary
        7.8.2 Johnson & Johnson Business Overview
        7.8.3 Johnson & Johnson Attention Deficit Hyperactivity Disorder Major Product Offerings
        7.8.4 Johnson & Johnson Attention Deficit Hyperactivity Disorder Revenue in Global Market (2017-2022)
        7.8.5 Johnson & Johnson Key News
    7.9 Purdue Parma
        7.9.1 Purdue Parma Corporate Summary
        7.9.2 Purdue Parma Business Overview
        7.9.3 Purdue Parma Attention Deficit Hyperactivity Disorder Major Product Offerings
        7.9.4 Purdue Parma Attention Deficit Hyperactivity Disorder Revenue in Global Market (2017-2022)
        7.9.5 Purdue Parma Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Attention Deficit Hyperactivity Disorder Market Opportunities & Trends in Global Market
    Table 2. Attention Deficit Hyperactivity Disorder Market Drivers in Global Market
    Table 3. Attention Deficit Hyperactivity Disorder Market Restraints in Global Market
    Table 4. Key Players of Attention Deficit Hyperactivity Disorder in Global Market
    Table 5. Top Attention Deficit Hyperactivity Disorder Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Attention Deficit Hyperactivity Disorder Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Attention Deficit Hyperactivity Disorder Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Attention Deficit Hyperactivity Disorder Product Type
    Table 9. List of Global Tier 1 Attention Deficit Hyperactivity Disorder Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Attention Deficit Hyperactivity Disorder Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Attention Deficit Hyperactivity Disorder Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Attention Deficit Hyperactivity Disorder Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Attention Deficit Hyperactivity Disorder Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Attention Deficit Hyperactivity Disorder Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Attention Deficit Hyperactivity Disorder Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Attention Deficit Hyperactivity Disorder Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2023-2028
    Table 30. Eli Lilly Corporate Summary
    Table 31. Eli Lilly Attention Deficit Hyperactivity Disorder Product Offerings
    Table 32. Eli Lilly Attention Deficit Hyperactivity Disorder Revenue (US$, Mn), (2017-2022)
    Table 33. Novartis Corporate Summary
    Table 34. Novartis Attention Deficit Hyperactivity Disorder Product Offerings
    Table 35. Novartis Attention Deficit Hyperactivity Disorder Revenue (US$, Mn), (2017-2022)
    Table 36. Takeda Corporate Summary
    Table 37. Takeda Attention Deficit Hyperactivity Disorder Product Offerings
    Table 38. Takeda Attention Deficit Hyperactivity Disorder Revenue (US$, Mn), (2017-2022)
    Table 39. Pfizer Corporate Summary
    Table 40. Pfizer Attention Deficit Hyperactivity Disorder Product Offerings
    Table 41. Pfizer Attention Deficit Hyperactivity Disorder Revenue (US$, Mn), (2017-2022)
    Table 42. GlaxoSmithKline Corporate Summary
    Table 43. GlaxoSmithKline Attention Deficit Hyperactivity Disorder Product Offerings
    Table 44. GlaxoSmithKline Attention Deficit Hyperactivity Disorder Revenue (US$, Mn), (2017-2022)
    Table 45. Mallinckrodt Corporate Summary
    Table 46. Mallinckrodt Attention Deficit Hyperactivity Disorder Product Offerings
    Table 47. Mallinckrodt Attention Deficit Hyperactivity Disorder Revenue (US$, Mn), (2017-2022)
    Table 48. Hisamitsu Corporate Summary
    Table 49. Hisamitsu Attention Deficit Hyperactivity Disorder Product Offerings
    Table 50. Hisamitsu Attention Deficit Hyperactivity Disorder Revenue (US$, Mn), (2017-2022)
    Table 51. Johnson & Johnson Corporate Summary
    Table 52. Johnson & Johnson Attention Deficit Hyperactivity Disorder Product Offerings
    Table 53. Johnson & Johnson Attention Deficit Hyperactivity Disorder Revenue (US$, Mn), (2017-2022)
    Table 54. Purdue Parma Corporate Summary
    Table 55. Purdue Parma Attention Deficit Hyperactivity Disorder Product Offerings
    Table 56. Purdue Parma Attention Deficit Hyperactivity Disorder Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Attention Deficit Hyperactivity Disorder Segment by Type in 2021
    Figure 2. Attention Deficit Hyperactivity Disorder Segment by Application in 2021
    Figure 3. Global Attention Deficit Hyperactivity Disorder Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Attention Deficit Hyperactivity Disorder Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Attention Deficit Hyperactivity Disorder Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Attention Deficit Hyperactivity Disorder Revenue in 2021
    Figure 8. By Type - Global Attention Deficit Hyperactivity Disorder Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Attention Deficit Hyperactivity Disorder Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Attention Deficit Hyperactivity Disorder Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Attention Deficit Hyperactivity Disorder Revenue Market Share, 2017-2028
    Figure 12. US Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Attention Deficit Hyperactivity Disorder Revenue Market Share, 2017-2028
    Figure 16. Germany Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
    Figure 17. France Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Attention Deficit Hyperactivity Disorder Revenue Market Share, 2017-2028
    Figure 24. China Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
    Figure 28. India Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Attention Deficit Hyperactivity Disorder Revenue Market Share, 2017-2028
    Figure 30. Brazil Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Attention Deficit Hyperactivity Disorder Revenue Market Share, 2017-2028
    Figure 33. Turkey Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Attention Deficit Hyperactivity Disorder Revenue, (US$, Mn), 2017-2028
    Figure 37. Eli Lilly Attention Deficit Hyperactivity Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Novartis Attention Deficit Hyperactivity Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Takeda Attention Deficit Hyperactivity Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Pfizer Attention Deficit Hyperactivity Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. GlaxoSmithKline Attention Deficit Hyperactivity Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Mallinckrodt Attention Deficit Hyperactivity Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Hisamitsu Attention Deficit Hyperactivity Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Johnson & Johnson Attention Deficit Hyperactivity Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Purdue Parma Attention Deficit Hyperactivity Disorder Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Eli Lilly
Novartis
Takeda
Pfizer
GlaxoSmithKline
Mallinckrodt
Hisamitsu
Johnson & Johnson
Purdue Parma
Frequently Asked Questions
Attention Deficit Hyperactivity Disorder Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Attention Deficit Hyperactivity Disorder Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Attention Deficit Hyperactivity Disorder Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports